VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy
Clinical trial NCT06253364 · COMPLETED
Trial details
- NCT number
- NCT06253364
- Sponsor
- Chen Xiaoping
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-01
- Primary completion
- 2023-06-30
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.